Polaryx Therapeutics
PLYX
Polaryx Therapeutics (PLYX) news
Recent news
Trading halted: (Flynx) Due to limit-up limit-down trading pause
AInvest Wire · 2d agoPolaryx Therapeutics appoints Dr. Will Charlton as chief medical officer
AInvest Wire · Sep 1, 2026Polaryx Therapeutics, Inc.: H.C. Wainwright initiates coverage with buy rating and target price $7
H.C. Wainwright & Co. has initiated coverage on Polaryx Therapeutics, Inc. with a "Buy" rating and a target price of $7 per share. The decision reflects the firm’s assessment of the company’s strong pipeline and strategic positioning in the biopharmaceutical sector. While specific details of the…
AInvest Wire · Jul 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.